JP2002522386A5 - - Google Patents

Download PDF

Info

Publication number
JP2002522386A5
JP2002522386A5 JP2000563276A JP2000563276A JP2002522386A5 JP 2002522386 A5 JP2002522386 A5 JP 2002522386A5 JP 2000563276 A JP2000563276 A JP 2000563276A JP 2000563276 A JP2000563276 A JP 2000563276A JP 2002522386 A5 JP2002522386 A5 JP 2002522386A5
Authority
JP
Japan
Prior art keywords
group
hydrogen
indole
ethyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000563276A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002522386A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/017460 external-priority patent/WO2000007591A1/en
Publication of JP2002522386A publication Critical patent/JP2002522386A/ja
Publication of JP2002522386A5 publication Critical patent/JP2002522386A5/ja
Withdrawn legal-status Critical Current

Links

JP2000563276A 1998-08-03 1999-08-02 インドールsPLA2インヒビター Withdrawn JP2002522386A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9510998P 1998-08-03 1998-08-03
US60/095,109 1998-08-03
PCT/US1999/017460 WO2000007591A1 (en) 1998-08-03 1999-08-02 INDOLE sPLA2 INHIBITORS

Publications (2)

Publication Number Publication Date
JP2002522386A JP2002522386A (ja) 2002-07-23
JP2002522386A5 true JP2002522386A5 (cg-RX-API-DMAC7.html) 2006-07-27

Family

ID=22249729

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000563276A Withdrawn JP2002522386A (ja) 1998-08-03 1999-08-02 インドールsPLA2インヒビター

Country Status (6)

Country Link
US (2) US6608099B1 (cg-RX-API-DMAC7.html)
EP (1) EP1100493A4 (cg-RX-API-DMAC7.html)
JP (1) JP2002522386A (cg-RX-API-DMAC7.html)
AU (1) AU5331499A (cg-RX-API-DMAC7.html)
CA (1) CA2338727A1 (cg-RX-API-DMAC7.html)
WO (1) WO2000007591A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002522386A (ja) * 1998-08-03 2002-07-23 イーライ・リリー・アンド・カンパニー インドールsPLA2インヒビター
AU2001236440A1 (en) * 2000-01-25 2001-08-07 Eli Lilly And Company Method for the treatment of inflammation with spla2 inhibitors
AU2001232734A1 (en) * 2000-03-09 2001-09-17 Eli Lilly And Company Compositions containing potential spla2 inhibitors for the treatment of pain
CN1450893A (zh) * 2000-07-14 2003-10-22 伊莱利利公司 治疗脓毒症的方法
JP2005527466A (ja) 2001-08-09 2005-09-15 イーライ・リリー・アンド・カンパニー sPLA2インヒビターとしてのシクロヘプトBインドール誘導体
JP2005527464A (ja) * 2001-08-09 2005-09-15 イーライ・リリー・アンド・カンパニー sPLA2インヒビターとしてのシクロヘプタBインドール誘導体
AUPS282602A0 (en) 2002-06-07 2002-06-27 Garvan Institute Of Medical Research Method of inhibiting cell proliferation
EP1479677A1 (en) * 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH New indole derivatives as factor xa inhibitors
CA2565387A1 (en) * 2004-05-03 2005-11-17 Ilypsa, Inc. Modulation of lysophosphatidylcholine and treatment of diet-induced conditions
MX2008005661A (es) * 2005-11-03 2008-12-15 Ilypsa Inc Inhibidores de fosfolipasa, que incluyen inhibidores de fosfolipasa multivalente, y uso de los mismos, que incluyen como inhibidores de fosfolipasa localizadas en el lumen.
JP2009514883A (ja) * 2005-11-03 2009-04-09 イリプサ, インコーポレイテッド アザインドール化合物およびホスホリパーゼa2インヒビターとしてのその使用
EP1948602A2 (en) * 2005-11-03 2008-07-30 Ilypsa, Inc. Indole compounds having c4-amide substituents and use thereof as phospholipase-a2 inhibitors
EP1960356A2 (en) * 2005-11-03 2008-08-27 Ilypsa, Inc. Multivalent indole compounds and use thereof as phospholipase-a2 inhibitors
EP1948604A1 (en) * 2005-11-03 2008-07-30 Ilypsa, Inc. Indole compounds having c4-acidic substituents and use thereof as phospholipase-a2 inhibitors
CN107233337A (zh) 2009-04-29 2017-10-10 阿马里纳药物爱尔兰有限公司 含有epa和心血管剂的药物组合物以及使用其的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL109311A0 (en) 1993-04-16 1994-07-31 Lilly Co Eli 1H-indole-3-acetamide sPla2 inhibitors
IL109309A (en) 1993-04-16 2000-06-29 Lilly Co Eli 1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them
EP1950200B1 (en) * 1994-04-01 2012-01-11 Eli Lilly And Company [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid methyl ester as sPLA2 inhibitor
US5641800A (en) * 1994-07-21 1997-06-24 Eli Lilly And Company 1H-indole-1-functional sPLA2 inhibitors
JP2002522386A (ja) * 1998-08-03 2002-07-23 イーライ・リリー・アンド・カンパニー インドールsPLA2インヒビター
CA2338855A1 (en) * 1998-08-03 2000-02-17 Eli Lilly And Company Indole spla2 inhibitors

Similar Documents

Publication Publication Date Title
RU2328485C2 (ru) Производные индолинфенилсульфамида
JP2002508362A5 (ja) 1−置換−1−アミノメチル−シクロアルカン誘導体(=ガバペンチン類縁体)
WO2001087845A3 (en) N-containing heterocyclic compounds and their use as 5-ht antagonists
JP5702392B2 (ja) キサンチンオキシダーゼ阻害剤として効果的な新規化合物、その製造方法及びそれを含有する医薬組成物
JP2002508352A5 (ja) 4(3)置換−4(3)−アミノメチル−(チオ)ピラン又はピペリジン誘導体(=ガバペンチン類似体)
JP2003528918A5 (cg-RX-API-DMAC7.html)
JP2004500347A5 (cg-RX-API-DMAC7.html)
JP2002534523A5 (cg-RX-API-DMAC7.html)
JP2002522385A5 (cg-RX-API-DMAC7.html)
KR950701622A (ko) 안기오텐신 ii 리셉터 안타고니스트 특성을 지니는 치환된 1,2,3,4-테트라하이드로 이소퀴놀린(substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin ⅱ receptor antagonist properties)
JP2005510476A5 (cg-RX-API-DMAC7.html)
JP2007508359A5 (cg-RX-API-DMAC7.html)
LU92113I2 (fr) Perampanel et ses dérivés pharmaceutiquement acceptables (FYCOMPA)
JP2002543183A5 (cg-RX-API-DMAC7.html)
CA2401502A1 (en) Carboxylic acid derivatives as ip antagonists
JP2012505234A5 (cg-RX-API-DMAC7.html)
EA200000731A1 (ru) Альфа-аминоамидные производные, полезные в качестве анальгетических агентов
JP2005514398A5 (cg-RX-API-DMAC7.html)
GB0215650D0 (en) Bisarylsufonamide compounds
NL350019I2 (nl) Zuuranilidederivaten, de toepassing ervan voor hetbestrijden van Botrytis.
JP2002529532A5 (cg-RX-API-DMAC7.html)
JP2004501940A5 (cg-RX-API-DMAC7.html)
JP2007534702A5 (cg-RX-API-DMAC7.html)
KR960706477A (ko) 신규한 이미다졸 유도체 및 이의 제조방법(Novel imidazole derivative and process for producing the same)
JP2002527414A5 (cg-RX-API-DMAC7.html)